Clinical Trial Update: Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 randomized trial comparing terlipressin plus albumin to midodrine plus octreotide for hepatorenal syndrome in cirrhosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatorenal Syndrome

Drugs mentioned

• Albumin
• Midodrine (Midodrine)
• OCTREOTIDE (OCTREOTIDE ACETATE)
• Terlipressin (terlipressin)

Snippet

Sponsor: University of Padova | Conditions: Cirrhosis, Hepatorenal Syndrome | Phase 2, Phase 3 | Status: TERMINATED